Profile data is unavailable for this security.
About the company
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT), and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The Company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for obesity, and obesity-related diseases and conditions (HT-VA).
- Revenue in USD (TTM)0.00
- Net income in USD-12.16m
- Incorporated2017
- Employees2.00
- LocationHoth Therapeutics Inc1177 Avenue Of The Americas5Th Floor Suite 5066NEW YORK 10036United StatesUSA
- Phone+1 (646) 756-2997
- Websitehttps://hoththerapeutics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tian'an Pharmaceutical Co Ltd | 10.65m | 3.14m | 8.00m | -- | 0.0445 | 0.0097 | 2.20 | 0.7511 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
| Gelteq Ltd | 118.04k | -4.74m | 8.45m | 7.00 | -- | 0.7499 | -- | 71.55 | -0.5018 | -0.5018 | 0.0125 | 1.05 | 0.0078 | -- | 0.5155 | 16,863.19 | -31.47 | -17.38 | -40.60 | -19.16 | -- | -- | -4,011.74 | -4,507.46 | -- | -3.52 | 0.2106 | -- | -- | -- | -87.40 | -- | -- | -- |
| Biofrontera Inc | 37.17m | -17.57m | 8.97m | 92.00 | -- | -- | -- | 0.2413 | -1.84 | -1.84 | 4.07 | -0.2216 | 2.19 | 2.44 | 9.45 | 403,967.40 | -103.57 | -48.03 | -339.69 | -77.55 | 64.41 | 48.93 | -47.28 | -60.99 | 0.8033 | -47.48 | 2.37 | -- | 9.54 | 7.35 | 11.78 | -- | -35.51 | -- |
| Integrated Biopharma Inc | 53.43m | 672.00k | 9.32m | 153.00 | 14.16 | 0.4548 | 9.41 | 0.1744 | 0.0212 | 0.0212 | 1.71 | 0.6597 | 2.07 | 4.45 | 12.77 | 349,183.00 | 2.60 | 9.98 | 3.28 | 13.68 | 9.75 | 10.74 | 1.26 | 4.58 | 1.92 | -- | 0.0072 | -- | 8.02 | 0.5933 | 482.30 | -30.67 | -0.8556 | -- |
| Cuprina Holdings (Cayman) Ltd | 24.04k | -2.24m | 9.37m | 14.00 | -- | 1.54 | -- | 389.69 | -0.1235 | -0.1235 | 0.0013 | 0.2836 | 0.0049 | 13.39 | 0.7976 | 1,717.34 | -44.56 | -- | -131.50 | -- | -69.27 | -- | -9,194.46 | -- | 3.58 | -306.25 | 0.0244 | -- | -52.05 | -- | -39.39 | -- | -- | -- |
| Bon Natural Life Ltd | 18.67m | -1.99m | 10.18m | 96.00 | 18.75 | 0.2331 | -- | 0.5452 | 0.088 | 0.088 | 6.74 | 7.08 | 0.2541 | 6.07 | 1.64 | 194,486.40 | -2.79 | 5.82 | -3.97 | 7.86 | 20.77 | 28.53 | -10.98 | 10.83 | 1.61 | -4.44 | 0.1735 | 0.00 | -21.70 | 0.4899 | -577.58 | -- | 18.20 | -- |
| Akari Therapeutics PLC (ADR) | 0.00 | -15.77m | 11.24m | 8.00 | -- | -- | -- | -- | -0.600 | -0.600 | 0.00 | -- | 0.00 | -- | -- | 0.00 | -65.57 | -112.46 | -136.47 | -257.78 | -- | -- | -- | -- | -- | -27.77 | 0.0854 | -- | -- | -- | -97.75 | -- | -- | -- |
| Nexgel Inc | 11.67m | -2.88m | 11.40m | 19.00 | -- | 2.20 | -- | 0.9773 | -0.3796 | -0.3796 | 1.53 | 0.6369 | 1.05 | 3.79 | 13.46 | 613,947.40 | -25.14 | -39.08 | -36.83 | -49.79 | 38.30 | 19.60 | -23.91 | -105.40 | 1.08 | -51.36 | 0.1439 | -- | 112.47 | 64.69 | -3.93 | -- | -- | -- |
| Lotus Pharmaceuticals Inc | 70.79m | 1.72m | 12.69m | 233.00 | 0.0868 | 0.0013 | 3.29 | 0.1793 | 0.0553 | 0.0553 | 2.56 | 3.58 | 0.6321 | 37.27 | 17.85 | 303,836.90 | 1.55 | 22.84 | 1.71 | 26.40 | 35.10 | 41.62 | 2.45 | 19.93 | 0.4428 | 30.80 | 0.0516 | 0.00 | 28.71 | 31.70 | -12.22 | 51.11 | 70.48 | -- |
| Cellectar Biosciences Inc | 0.00 | -18.85m | 14.03m | 11.00 | -- | 1.41 | -- | -- | -10.78 | -10.78 | 0.00 | 2.94 | 0.00 | -- | -- | 0.00 | -72.62 | -104.57 | -141.24 | -133.43 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -4.23 | -- | 33.54 | -- |
| Hoth Therapeutics Inc | 0.00 | -12.16m | 14.46m | 2.00 | -- | 1.71 | -- | -- | -1.06 | -1.06 | 0.00 | 0.5442 | 0.00 | -- | -- | 0.00 | -138.61 | -129.47 | -154.67 | -144.30 | -- | -- | -- | -- | -- | -493.48 | 0.00 | -- | -- | -- | -4.37 | -- | -- | -- |
| CASI Pharmaceuticals Inc | 26.85m | -49.38m | 15.82m | 233.00 | -- | -- | -- | 0.5894 | -2.98 | -2.98 | 1.62 | -1.85 | 0.6096 | 1.60 | 4.22 | 115,218.90 | -107.02 | -36.27 | -277.91 | -51.90 | 53.68 | 57.36 | -175.56 | -124.01 | 0.236 | -13.27 | -- | -- | -15.77 | 47.19 | -45.62 | -- | -55.67 | -- |
| Lexaria Bioscience Corp | 522.00k | -10.79m | 15.87m | 7.00 | -- | 2.88 | -- | 30.40 | -0.5743 | -0.5743 | 0.0272 | 0.221 | 0.0659 | -- | 2.97 | 74,571.43 | -136.35 | -102.60 | -145.39 | -105.78 | 100.00 | 87.95 | -2,069.41 | -1,579.38 | -- | -285.30 | 0.00 | -- | 52.05 | 17.53 | -105.37 | -- | 48.50 | -- |
| Global Pharmatech Inc. | 3.18m | -2.24m | 20.76m | 217.00 | -- | 0.1459 | -- | 6.53 | -0.0964 | -0.0964 | 0.1367 | 0.3428 | 0.2292 | 1.59 | 3.57 | 14,649.77 | -16.44 | -- | -22.55 | -- | 46.21 | -- | -71.75 | -- | 1.62 | -9.87 | 0.2223 | -- | 32.43 | -- | -142.03 | -- | -- | -- |
| Nutraproducts Inc | 0.00 | -821.94k | 20.92m | 0.00 | -- | 3.50 | -- | -- | -1.31 | -1.31 | 0.00 | 0.2973 | 0.00 | -- | -- | -- | -513.70 | -1,177.23 | -740.45 | -- | -- | -- | -- | -- | -- | -385.17 | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Data as of Feb 12 2026. Currency figures normalised to Hoth Therapeutics Inc's reporting currency: US Dollar USD
7.28%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Renaissance Technologies LLCas of 30 Sep 2025 | 243.92k | 1.57% |
| Geode Capital Management LLCas of 30 Sep 2025 | 153.54k | 0.99% |
| Citadel Securities LLCas of 30 Sep 2025 | 143.47k | 0.93% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 129.69k | 0.84% |
| Virtu Americas LLCas of 30 Sep 2025 | 113.41k | 0.73% |
| HRT Financial LPas of 30 Sep 2025 | 85.33k | 0.55% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 84.32k | 0.54% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 63.94k | 0.41% |
| UBS Securities LLCas of 31 Dec 2025 | 56.19k | 0.36% |
| Jane Street Capital LLCas of 30 Sep 2025 | 54.94k | 0.35% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
